Biotech startups in Amsterdam, The Netherlands
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| VectorY | Amsterdam | Series A | $138.0M | 2023-11-13 |
| Flindr Therapeutics | Amsterdam | Series A | $21.4M | 2024-04-24 |
| Hypherdata | Amsterdam | Seed | $939K | 2024-08-27 |
| VUS Diagnostics | Amsterdam | Pre-seed | $322K | 2023-11-06 |
4 rows of the CSV in 5 of its 18 columns.
- The 23 biotech startups in Amsterdam, The Netherlands have raised $330.0M in total.
- 1 of them closed their most recent round in the last 12 months, $10.0M combined.
- The largest of those rounds is NovaGen Group's $10.0M seed round, dated September 2026.
- Innovatiefonds Noord-Holland is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 17 companies (74%).
- 43% were founded in 2020 or later; the median founding year is 2019.
- The most common team size is 1 to 10 employees (43% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
1 of 23| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| VectorY | VectorY develops gene therapies for central nervous system, somatic, and muscle diseases. | Biotech | Series A | $138.0M | 2023-11-13 | $175.6M | Insight Partners, Benhamou Global Ventures, Forbion Capital Partners +2 | 51 to 100 | 2020 |
Table 1. Biotech startups in Amsterdam, The Netherlands: the 1 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 23.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Innovatiefonds Noord-Holland | Venture capital firm | Amsterdam, The Netherlands | 2 | 9% | ||
| 2 | Insight Partners | Private equity firm | New York, United States | 1 | 4% | ||
| 3 | Forbion Capital Partners | Private equity firm | Naarden, The Netherlands | 1 | 4% | ||
| 4 | Benhamou Global Ventures | Venture capital firm | Menlo Park, United States | 1 | 4% | ||
| 5 | EQT Life Sciences | Private equity firm | Amsterdam, The Netherlands | 1 | 4% | ||
| 6 | MRL Ventures Fund | Corporate venture arm | Cambridge, United States | 1 | 4% | ||
| 7 | Johnson & Johnson Innovation | Corporate venture arm | Cambridge, United States | 1 | 4% | ||
| 8 | Qbic Fund | Micro VC fund | Ghent, Belgium | 1 | 4% | ||
| 9 | BOM | Government investment office | Tilburg, The Netherlands | 1 | 4% | ||
| 10 | V-Bio Ventures | Venture capital firm | Ghent, Belgium | 1 | 4% | ||
| 11 | CB Investment Management | Investment bank | Bratislava, Slovakia (Slovak Republic) | 1 | 4% | ||
| 12 | Zero One Hundred | Venture capital firm | Bratislava, Slovakia (Slovak Republic) | 1 | 4% | ||
| 13 | N1 | Venture capital firm | Prague, Czech Republic | 1 | 4% | ||
| 14 | Antler | Venture capital firm | Singapore | 1 | 4% |
Table 2. Biotech startups in Amsterdam, The Netherlands: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 17 | 74% | $320.0M |
| Artificial intelligence | 3 | 13% | $13.3M |
| Software | 3 | 13% | $13.3M |
Table 3. Biotech startups in Amsterdam, The Netherlands by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Pre-seed | 7 | 30% | $300K |
| Seed | 9 | 39% | $1.3M |
| Series A | 4 | 17% | $110.0M |
| Series B | 2 | 9% | $8.9M |
| Series C | 1 | 4% | $10.9M |
Table 4. Biotech startups in Amsterdam, The Netherlands by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| September 2026 | 1 | 100% | $10.0M |
Table 5. Biotech startups in Amsterdam, The Netherlands: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 1 | 4% | $10.0M |
| 2025 | 1 | 4% | $1.3M |
| 2024 | 2 | 9% | $22.3M |
| 2023 | 3 | 13% | $138.7M |
| 2022 | 6 | 26% | $43.9M |
| 2021 | 1 | 4% |
Table 6. Biotech startups in Amsterdam, The Netherlands by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 2 | 9% |
| 2020 to 2022 | 8 | 35% |
| 2015 to 2019 | 7 | 30% |
| 2010 to 2014 | 1 | 4% |
| Before 2010 | 5 | 22% |
Table 7. Biotech startups in Amsterdam, The Netherlands by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 9 | 43% |
| 11 to 50 | 9 | 43% |
| 51 to 100 | 2 | 10% |
| 501 to 1,000 | 1 | 5% |
Table 8. Biotech startups in Amsterdam, The Netherlands by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Amsterdam, The Netherlands. On 16 November 2026 that is 23 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 1 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 23 rows: 7 have no round amount, 0 no city and 9 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Amsterdam, The Netherlands are on the list?
- 23, in the file dated 16 November 2026. 1 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 23 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.